Literature DB >> 17277101

Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition.

Angelic M G van der Aar1, Regien M R Sylva-Steenland, Jan D Bos, Martien L Kapsenberg, Esther C de Jong, Marcel B M Teunissen.   

Abstract

It is unknown whether closely related epidermal dendritic cells, Langerhans cells (LCs), and dermal dendritic cells (DDCs) have unique functions. In this study, we show that human DDCs have a broad TLR expression profile, whereas human LCs have a selective impaired expression of cell surface TLR2, TLR4, and TLR5, all involved in bacterial recognition. This distinct TLR expression profile is acquired during the TGF-beta1-driven development of LCs in vitro. Consequently, and in contrast to DDCs, LCs weakly respond to bacterial TLR2, TLR4, and TLR5 ligands in terms of cytokine production and maturation, as well as to whole Gram-positive and Gram-negative bacteria, whereas their responsiveness to viral TLR ligands and viruses is fully active and comparable to DDCs. Unresponsiveness of LCs to bacteria may be a mechanism that contributes to tolerance to bacterial commensals that colonize the skin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277101     DOI: 10.4049/jimmunol.178.4.1986

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

Review 1.  Targeting human dendritic cell subsets for improved vaccines.

Authors:  Hideki Ueno; Eynav Klechevsky; Nathalie Schmitt; Ling Ni; Anne-Laure Flamar; Sandra Zurawski; Gerard Zurawski; Karolina Palucka; Jacques Banchereau; Sangkon Oh
Journal:  Semin Immunol       Date:  2011-01-28       Impact factor: 11.130

2.  Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells.

Authors:  Ivan Rajkovic; Ana Dragicevic; Sasa Vasilijic; Biljana Bozic; Tanja Dzopalic; Sergej Tomic; Ivana Majstorovic; Dragana Vucevic; Jelena Djokic; Bela Balint; Miodrag Colic
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 3.  Dendritic cells and cytokines in human inflammatory and autoimmune diseases.

Authors:  Patrick Blanco; A Karolina Palucka; Virginia Pascual; Jacques Banchereau
Journal:  Cytokine Growth Factor Rev       Date:  2008-02       Impact factor: 7.638

Review 4.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

5.  TGF-beta1 Inhibits TLR-mediated odontoblast responses to oral bacteria.

Authors:  O V Horst; K A Tompkins; S R Coats; P H Braham; R P Darveau; B A Dale
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

Review 6.  Langerhans cells as targets for immunotherapy against skin cancer.

Authors:  Patrizia Stoitzner; Florian Sparber; Christoph H Tripp
Journal:  Immunol Cell Biol       Date:  2010-03-30       Impact factor: 5.126

7.  Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells.

Authors:  Rebecca J Dearman; Marie Cumberbatch; Gavin Maxwell; David A Basketter; Ian Kimber
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

8.  TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Authors:  Marein A W P de Jong; Lot de Witte; Menno J Oudhoff; Sonja I Gringhuis; Philippe Gallay; Teunis B H Geijtenbeek
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 9.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

10.  Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

Authors:  Eynav Klechevsky; Maochang Liu; Rimpei Morita; Romain Banchereau; Luann Thompson-Snipes; A Karolina Palucka; Hideki Ueno; Jacques Banchereau
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.